Centamin plc (LON:CEY – Get Free Report)’s stock price fell 7.7% during mid-day trading on Thursday . The company traded as low as GBX 116.66 ($1.51) and last traded at GBX 119.40 ($1.54). 9,597,326 shares changed hands during mid-day trading, an increase of 134% from the average session volume of 4,109,497 shares. The stock had previously closed at GBX 129.40 ($1.67).
Analysts Set New Price Targets
CEY has been the subject of a number of research analyst reports. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 160 ($2.07) price target on shares of Centamin in a report on Thursday, July 18th. Canaccord Genuity Group restated a “buy” rating and issued a GBX 150 ($1.94) price objective on shares of Centamin in a research report on Thursday.
View Our Latest Stock Analysis on CEY
Centamin Stock Performance
Centamin Increases Dividend
The business also recently announced a dividend, which will be paid on Friday, September 27th. Investors of record on Thursday, August 29th will be paid a $0.02 dividend. The ex-dividend date is Thursday, August 29th. This is a positive change from Centamin’s previous dividend of $0.02. This represents a yield of 1.35%. Centamin’s dividend payout ratio is presently 5,000.00%.
Insider Activity
In other Centamin news, insider Martin Horgan sold 95,783 shares of the company’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of GBX 123 ($1.59), for a total transaction of £117,813.09 ($152,370.78). Corporate insiders own 0.21% of the company’s stock.
Centamin Company Profile
Centamin plc, together with its subsidiaries, engages in the exploration, mining, and development of gold and precious metals in Egypt, Côte d'Ivoire, Burkina Faso, Jersey, the United Kingdom, and Australia. Its principal asset is the Sukari Gold Mine project, which covers an area of approximately 160 square kilometers located in the Eastern Desert of Egypt.
See Also
- Five stocks we like better than Centamin
- 3 REITs to Buy and Hold for the Long Term
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- With Risk Tolerance, One Size Does Not Fit All
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- ESG Stocks, What Investors Should Know
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for Centamin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centamin and related companies with MarketBeat.com's FREE daily email newsletter.